NCT00405548View on ClinicalTrials.gov

Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

August 31, 2012

Conditions
Left Ventricular Diastolic Dysfunction
Interventions
DRUG

BNP (nesiritide)

DRUG

Placebo

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Scios, Inc.

INDUSTRY

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

Mayo Clinic

OTHER

NCT00405548 - Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function. | Biotech Hunter | Biotech Hunter